Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127299831 | 12729983 | 1 | I | 20150426 | 20160831 | 20160909 | 20160909 | EXP | US-TEVA-691559USA | TEVA | 76.87 | YR | M | Y | 0.00000 | 20160909 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127299831 | 12729983 | 1 | PS | METOPROLOL. | METOPROLOL | 1 | Unknown | 74217 | |||||||||||
| 127299831 | 12729983 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | Unknown | U | 75752 | ||||||||||
| 127299831 | 12729983 | 3 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 160 MILLIGRAM DAILY; | U | 0 | CAPSULE | QD | |||||||
| 127299831 | 12729983 | 4 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 160 MILLIGRAM DAILY; | U | 0 | 160 | MG | CAPSULE | QD | |||||
| 127299831 | 12729983 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127299831 | 12729983 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 127299831 | 12729983 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 127299831 | 12729983 | 8 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0 | ||||||||||||
| 127299831 | 12729983 | 9 | C | FAMOTIDINE. | FAMOTIDINE | 1 | 0 | ||||||||||||
| 127299831 | 12729983 | 10 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127299831 | 12729983 | 3 | Prostate cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127299831 | 12729983 | HO |
| 127299831 | 12729983 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127299831 | 12729983 | Arthralgia | |
| 127299831 | 12729983 | Asthenia | |
| 127299831 | 12729983 | Dizziness | |
| 127299831 | 12729983 | Dyspnoea | |
| 127299831 | 12729983 | Gait disturbance | |
| 127299831 | 12729983 | Heart rate decreased | |
| 127299831 | 12729983 | Heart rate irregular | |
| 127299831 | 12729983 | Hot flush | |
| 127299831 | 12729983 | Hypertension | |
| 127299831 | 12729983 | Memory impairment | |
| 127299831 | 12729983 | Musculoskeletal pain | |
| 127299831 | 12729983 | Prostatic specific antigen decreased | |
| 127299831 | 12729983 | Pulmonary congestion | |
| 127299831 | 12729983 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127299831 | 12729983 | 1 | 2015 | 0 | ||
| 127299831 | 12729983 | 2 | 2015 | 0 | ||
| 127299831 | 12729983 | 3 | 20150408 | 20150428 | 0 | |
| 127299831 | 12729983 | 4 | 20150515 | 201607 | 0 |